Last update 13 Oct 2025

Live Recombinant Vaccinia Virus Expressing The Human Papilloma Virus 16 and 18 E6 and E7 Proteins(EORTC)

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms
TA-HPV
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsUrogenital Diseases
Active Indication-
Inactive Indication
Uterine Cervical Cancer
Originator Organization
EORTCEORTC
Active Organization-
Inactive Organization
EORTCEORTC
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with Live Recombinant Vaccinia Virus Expressing The Human Papilloma Virus 16 and 18 E6 and E7 Proteins(EORTC)
NCT00002916
/ CompletedPhase 2IIT
A Phase II Trial in Patients With Early Cervical Cancer to Study The Safety and The Immunological Effects of Vaccination With TA-HPV, A Live Recombinant Vaccinia Virus Expressing The Human Papilloma Virus 16 and 18 E6 and E7 Proteins
100 Clinical Results associated with Live Recombinant Vaccinia Virus Expressing The Human Papilloma Virus 16 and 18 E6 and E7 Proteins(EORTC)
Login to view more data
100 Translational Medicine associated with Live Recombinant Vaccinia Virus Expressing The Human Papilloma Virus 16 and 18 E6 and E7 Proteins(EORTC)
Login to view more data
100 Patents (Medical) associated with Live Recombinant Vaccinia Virus Expressing The Human Papilloma Virus 16 and 18 E6 and E7 Proteins(EORTC)
Login to view more data
100 Deals associated with Live Recombinant Vaccinia Virus Expressing The Human Papilloma Virus 16 and 18 E6 and E7 Proteins(EORTC)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Uterine Cervical CancerPhase 2
Austria
EORTCEORTC
01 Nov 1996
Uterine Cervical CancerPhase 2
France
EORTCEORTC
01 Nov 1996
Uterine Cervical CancerPhase 2
Germany
EORTCEORTC
01 Nov 1996
Uterine Cervical CancerPhase 2
Netherlands
EORTCEORTC
01 Nov 1996
Uterine Cervical CancerPhase 2
Norway
EORTCEORTC
01 Nov 1996
Uterine Cervical CancerPhase 2
Sweden
EORTCEORTC
01 Nov 1996
Uterine Cervical CancerPhase 2
United Kingdom
EORTCEORTC
01 Nov 1996
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free